JP2007504169A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504169A5
JP2007504169A5 JP2006524951A JP2006524951A JP2007504169A5 JP 2007504169 A5 JP2007504169 A5 JP 2007504169A5 JP 2006524951 A JP2006524951 A JP 2006524951A JP 2006524951 A JP2006524951 A JP 2006524951A JP 2007504169 A5 JP2007504169 A5 JP 2007504169A5
Authority
JP
Japan
Prior art keywords
conjugate
poly
amino acid
composition
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006524951A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504169A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/028256 external-priority patent/WO2005021556A2/en
Publication of JP2007504169A publication Critical patent/JP2007504169A/ja
Publication of JP2007504169A5 publication Critical patent/JP2007504169A5/ja
Withdrawn legal-status Critical Current

Links

JP2006524951A 2003-08-29 2004-08-30 修飾されたプロテアーゼインヒビター Withdrawn JP2007504169A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49884503P 2003-08-29 2003-08-29
PCT/US2004/028256 WO2005021556A2 (en) 2003-08-29 2004-08-30 Modified protease inhibitors

Publications (2)

Publication Number Publication Date
JP2007504169A JP2007504169A (ja) 2007-03-01
JP2007504169A5 true JP2007504169A5 (cg-RX-API-DMAC7.html) 2007-09-13

Family

ID=34272739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524951A Withdrawn JP2007504169A (ja) 2003-08-29 2004-08-30 修飾されたプロテアーゼインヒビター

Country Status (6)

Country Link
US (1) US20070020252A1 (cg-RX-API-DMAC7.html)
EP (1) EP1663279A4 (cg-RX-API-DMAC7.html)
JP (1) JP2007504169A (cg-RX-API-DMAC7.html)
AU (1) AU2004268144A1 (cg-RX-API-DMAC7.html)
CA (1) CA2537113A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005021556A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
DE60333758D1 (de) 2002-06-07 2010-09-23 Dyax Corp Prevention und Verringerung von Ischemia
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US20050089515A1 (en) * 2003-08-29 2005-04-28 Dyax Corp. Poly-pegylated protease inhibitors
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
WO2006070012A1 (en) * 2004-12-30 2006-07-06 Ingenium Pharmaceuticals Ag Agents useful in treating inflammatory bowel disease
EP1981519B1 (en) * 2005-12-29 2017-12-27 Dyax Corp. Protease inhibition
SI2374472T1 (sl) * 2006-03-16 2018-11-30 Dyax Corp., Sestavki in postopki za zdravljenje oftalmoloških motenj
EP2344201A1 (en) * 2008-09-17 2011-07-20 Nektar Therapeutics Oligomer-protease inhibitor conjugates
JP2013516389A (ja) 2009-01-06 2013-05-13 ダイアックス コーポレーション カリクレイン阻害剤による粘膜炎治療
WO2010144869A2 (en) * 2009-06-12 2010-12-16 Nektar Therapeutics Protease inhibitors
US20110094080A1 (en) * 2009-10-27 2011-04-28 William Karales Bar soap support mat
SI3459564T1 (sl) 2010-01-06 2022-06-30 Takeda Pharmaceutical Company Limited Proteini, ki vežejo plazemski kalikrein
JP2014506257A (ja) 2011-01-06 2014-03-13 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
IL295414B1 (en) 2014-03-27 2025-10-01 Takeda Pharmaceuticals Co Compositions and methods for treating macular edema due to diabetes
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
ATE529444T1 (de) * 1994-01-11 2011-11-15 Dyax Corp Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
JP3721538B2 (ja) * 1994-06-02 2005-11-30 メレル ファーマスーティカルズ インコーポレイテッド エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法
US5589359A (en) * 1994-08-05 1996-12-31 Chiron Corporation Chimeric proteins
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
WO2000032772A2 (en) * 1998-11-30 2000-06-08 Eli Lilly And Company Erythropoietic compounds
HRP20020387A2 (en) * 1999-11-12 2005-10-31 Maxygen Holdings Ltd. Interferon gamma conjugates
US6544760B2 (en) * 1999-12-22 2003-04-08 Zymogenetics, Inc. Kunitz domain polypeptide Zkun11
CA2445494A1 (en) * 2001-05-11 2002-11-21 Aradigm Corporation Optimization of the molecular properties and formulation of proteins delivered by inhalation
AR033903A1 (es) * 2001-05-21 2004-01-07 Inhale Therapeutic Syst Una composicion de insulina modificada quimicamente para la administracion pulmonar
AU2003257467B2 (en) * 2002-07-24 2008-02-28 F. Hoffmann-La Roche Ag Pegylated T20 polypeptide
MXPA05000796A (es) * 2002-07-24 2005-04-19 Hoffmann La Roche Aditivos de acidos polialquilenglicolicos.
US7314613B2 (en) * 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US20050089515A1 (en) * 2003-08-29 2005-04-28 Dyax Corp. Poly-pegylated protease inhibitors
US20060228331A1 (en) * 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants

Similar Documents

Publication Publication Date Title
JP2007504169A5 (cg-RX-API-DMAC7.html)
ES2226191T3 (es) Copolimeros de poli (oxido de aquileno) estrictamente alternantes.
JP4745664B2 (ja) カンプトテシン類の高分子誘導体
JP2012502990A5 (cg-RX-API-DMAC7.html)
US6602497B1 (en) Strictly alternating poly(alkylene oxide ether) copolymers
AU730969B2 (en) Discrete-length polyethylene glycols
US5840900A (en) High molecular weight polymer-based prodrugs
PL193352B1 (pl) Koniugat poliol-interferon ß, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
KR101644658B1 (ko) 하이드록시아파타이트-표적 다중팔 중합체 및 그로부터 제조된 컨쥬게이트
JP2014501765A5 (cg-RX-API-DMAC7.html)
US7504477B2 (en) Polyalkylene glycol acid additives
JP2002508400A5 (cg-RX-API-DMAC7.html)
JP2010503706A (ja) リジン系ポリマーリンカー
JP2005538035A5 (cg-RX-API-DMAC7.html)
JP2014503548A5 (cg-RX-API-DMAC7.html)
CN101420962A (zh) 经修饰的大分子
CA2596977A1 (en) Pyy agonists and uses thereof
JP4805911B2 (ja) Hiv侵入阻害剤のポリマー系組成物及び複合体
IL170424A (en) Compositions containing conjugates of a polymer and a factor viii moiety
JP2008542399A5 (cg-RX-API-DMAC7.html)
JP2005504006A5 (cg-RX-API-DMAC7.html)
US20080206184A1 (en) Chemically Modified Protein Compositions and Methods
US7863408B2 (en) Body fluid compatible and biocompatible resin
JP2008519858A5 (cg-RX-API-DMAC7.html)
US7589099B2 (en) 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists